It is termed a focused therapy because it specially targets the CD38 which might be overexpressed over the multiple myeloma cells. Daratumumab is from a class of medicines called CD38 monoclonal antibodies. DARZALEX® is offered being an intravenous (IV) infusion after dilution at sixteen mg/kg of true physique weight2 In https://johne549nps6.blogcudinti.com/profile